According to Bloomberg Buissnesweek on ADHD Drug
Source: Reuters: Health - September 16, 2023 Category: Consumer Health News Source Type: news

Revolutionary treatment could save 5,000 patients from amputations each year as NHS watchdog considers new British research into critical limb ischaemia
The procedure, called LimFlow, treats a type of blood vessel disease called critical limb ischaemia, where blockages in the arteries cut off the blood supply to the legs and feet.
Source: the Mail online | Health - September 16, 2023 Category: Consumer Health News Source Type: news

Jury Selection Controversy: Prosecutors Criticize ADHD, Effective Altruism Voir Dire Questions in Bankman-Fried Trial
Sam Bankman-Fried’s legal team and federal prosecutors are clashing over what can be asked of potential jurors before his trial begins next month. The defense and prosecution submitted dueling proposed questions on Thursday, with each side accusing the other of trying to inappropriately sway the…#sambankmanfried #sbfteam #voirdire #ftx #bankmanfried #damianwilliams #alamedaresearch
Source: Reuters: Health - September 16, 2023 Category: Consumer Health News Source Type: news

Trump Decries ' Double Standard ' In Documents Case, Pointing To Treatment Of Hilary Clinton
Trump Decries 'Double Standard' In Documents Case, Pointing To Treatment Of Hilary Clinton Authored by Samantha Flom via The Epoch Times (emphasis ours), The former president says he is unconcerned because he's 'fighting for the people.' Former President Donald Trump arrives for departure at…#samanthaflom #epochtimes #donaldtrump #atlanta #hartsfield #fultoncounty #joeraedlegettyimages #megynkellyshow #democrat #justicedepartment
Source: Reuters: Health - September 16, 2023 Category: Consumer Health News Source Type: news

U.S. Attorney dismisses ADHD, altruism queries in FTX case jury selection
Both parties agree on questioning potential jurors about their views on cryptocurrency. U.S. Attorney Damian Williams has dismissed four of the 14 voir dire questions proposed by the defense. The trial date for Sam Bankman-Fried is approaching, and both defense and prosecution are at odds over…#damianwilliams #sambankmanfried #ftx #southerndistrict #lewiskaplan #bankmanfried #bitcoin #newyorkcity
Source: Reuters: Health - September 16, 2023 Category: Consumer Health News Source Type: news

An early care void: the injury experience and perceptions of treatment among knee-injured individuals and healthcare professionals - a qualitative interview study - Holm PM, Simon ÿ C, Brydegaard NK, Høgsgaard D, Thorborg K, Møller M, Whittaker JL, Roos EM, Skou ST.
OBJECTIVES: To better comprehend the initial injury experience and care requirements of knee-injured individuals, as well as healthcare professionals' interactions with early care. DESIGN: Qualitative interviews. SETTING: Public healthcare in D...
Source: SafetyLit - September 16, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Activation of autophagy after blast-induced traumatic brain injury in mice - Zhou Y, Song Y, Zhu L.
Injury mechanism and treatment of blast-induced traumatic brain injury (bTBI) has not made a breakthrough so far. Previous reports demonstrate autophagy is involved in regulating the pathophysiological process after TBI. Therefore, this study explored whet...
Source: SafetyLit - September 16, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

How to Avoid the Tripledemic of Respiratory Diseases This Winter
[time-brightcove not-tgx=”true”] “Tripledemic“ jumped into our vocabulary and lives last year, referring to the winter surges of three respiratory viruses—RSV (respiratory syncytial virus), flu (influenza), and COVID-19. The tripledemic of 2022 infected millions, overwhelmed hospital systems, and killed more than 100,000 people in the U.S. over the 4-month peak span of these viruses. As much as we hoped that respiratory illness would fade with the COVID-19 public health emergency ending, we must recognize that these viruses will continue to impact us for years. As the school year b...
Source: TIME: Health - September 16, 2023 Category: Consumer Health News Authors: Scott A. Rivkees Tags: Uncategorized freelance Source Type: news

New study brings MDMA as treatment for PTSD closer to FDA approval
MDMA, commonly referred to as “ecstasy” or “molly,” is on its way to becoming the first psychedelic to receive approval from the Food and Drug Administration (FDA) after a study conducted by an industry-leading research group found that the drug was effective in treating moderate and severe…#mdma #fda #maps #hispaniclatino #africanamericans #paytonnyquvest #numinuswellnessinc #rickdoblin #gavinnewsom #oregon
Source: Reuters: Health - September 16, 2023 Category: Consumer Health News Source Type: news

Column: Mr. Ayers ends up in the hospital, a reminder that problems with nursing home oversight remain
A miscommunication about medication and treatment leads to a hospitalization for Nathaniel Ayers-- who keeps on playing
Source: L.A. Times - Health - September 16, 2023 Category: Consumer Health News Authors: Steve Lopez Source Type: news

Technical Assistance Webinar: Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment (R21/R33 Clinical Trial Not Allowed)
This pre-application webinar is for prospective applicants of RFA-MH-24-100: Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment.
Source: National Institute of Mental Health - September 16, 2023 Category: Psychiatry Authors: National Institute of Mental Health Source Type: news

Scientists create cancer-killing treatment they hope will annihilate most aggressive tumours
Scientists in Nottingham have discovered a new way to use nanoparticles to induce cell death, known scientifically as apoptosis, in glioblastoma cells - one of the most aggressive forms of brain cancer.
Source: the Mail online | Health - September 15, 2023 Category: Consumer Health News Source Type: news

FDA Approves Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia
Approval is for use in myelofibrosis patients with anemia regardless of prior myelofibrosis therapy Nearly all myelofibrosis patients are estimated to develop anemia over the course of the disease, and over 30% will discontinue treatment due to...
Source: Drugs.com - New Drug Approvals - September 15, 2023 Category: Drugs & Pharmacology Source Type: news

Humacyte enters critical phase for its bioengineered tissue
A Durham company is preparing to seek federal approval for its trauma treatment in order to advance to commercialization following positive trial data.
Source: bizjournals.com Health Care:Biotechnology headlines - September 15, 2023 Category: Biotechnology Authors: Zac Ezzone Source Type: news

Former J & J CEO Alex Gorsky named lead director at RI-based Neurotech Pharmaceuticals
Neurotech is developing novel technologies for the treatment of chronic eye diseases.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 15, 2023 Category: Pharmaceuticals Authors: Mary Serreze Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20